RUSSIAN FORCES TO STAY IN MALI TO FIGHT TERRORISM: KREMLIN. (PHOTO).

Image
 Russian forces to stay in Mali to fight terrorism: Kremlin The Kremlin said on Thursday that Russian forces would stay in Mali to help the country's government battle terrorists following an offensive over the weekend by Tuareg-led separatists and terrorists. Kremlin spokesman Dmitry Peskov made the statement after being asked by a reporter how Russia responded to a purported statement from the terrorists saying they wanted Russia to leave Mali. "Russia's presence there is, in fact, due to the need identified by the current government. Russia will continue, including in Mali, to combat extremism, terrorism and other harmful phenomena and will continue to provide assistance to the current government," said Peskov, AFP reported. The Russian Defence Ministry had claimed on Tuesday that units of its African Corps prevented an attempted coup on April 25, 2026 in Mali. It said in a statement that the African Corps units "inflicted irreparable losses" on superior ...

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).